October 2007

In This ArticleIntroductionAntidepressantsAntihistaminesGrowth HormonesOpioid Analgesics

Antihistamines

Clarinex (desloratadine) Syrup

Business organization: Schering

Drug Approving Compartmentalization: Model New Drug Sweat (Approval Date: 9/3/04)

Meter reading: This new drug manual labour for Clarinex (desloratadine) Syrup provides for the assistance of the consonant and non-nasal symptoms of perennial allergic rhinitis, and the symptomatic liberation of pruritus, reaction in the amount of hives, and size of hives, in patients with chronic idiopathic urticaria in children 6 months to 2 assemblage of age.

Dosing: Dosing is based on age:

Children 6 to 11 assemblage of age: The recommended dose of desloratadine syrup is 1 teaspoonful (2.5 mg in 5 mL) once daily.

Children 12 months to 5 time of life of age: The recommended dose of desloratadine syrup is 1/2 teaspoonful (1.25 mg in 2.5 mL) once daily.

Children 6 to 11 months of age: The recommended dose of desloratadine syrup is 2 mL (1.0 mg) once daily.

Clinical Summary: III pediatric clinical studies were conducted to assess the efficacy of desloratadine in allergic rhinitis, chronic idiopathic urticaria, and in subjects who were candidates for antihistamine therapy.
The clinical studies were 15-day, double-blind, placebo-controlled birth control device studies that enrolled 246 pediatric subjects 6 months to 11 time period of age.
This is a part of article October 2007 Taken from "Generic Clarinex (Desloratadine) Page" Information Blog